The significance of inflammatory factors ICPS in the treatment of severe COVID-19 patients

First, inflammatory factors ICPS - help severe and critical novel coronavirus pneumonia surveillance

The clinical manifestations of patients infected with the novel coronavirus (2019-nCoV) vary greatly, and mild patients only show low fever and slight fatigue, without pneumonia. Most severe patients develop dyspnea and hypoxemia one week after onset, and in severe cases rapid progression to acute respiratory distress syndrome, septic shock, difficult to correct metabolic acidosis and coagulation dysfunction. In addition, with the further development of severe disease, patients will have multiple organ problems, including myocardial damage, kidney failure and so on. Therefore, the immediate and rapid monitoring of severe and critical COVID-19 related indicators is of great significance for the timely and effective treatment of patients.